Assessment

Indacaterolacetat/Glycopyrroniumbromid/Mometasonfuroat

Asthma in adults not adequately controlled with a combination of a long-acting beta-2-agonist (LABA) and a high-dose inhaled corticosteroid (ICS) as maintenance therapy and who had 1 or more asthma exacerbations in the previous year